CETP TaqlB polymorphism in Turkish adults: Association with dyslipidemia and metabolic syndrome

Anadolu Kardiyoloji Dergisi

Volumn 8, Issue 5, 2008, Pages 324-330

  Özsait, Bilge ^a   Kömürcü Bayrak, Evrim ^a   Poda, Mehveş ^a   Can, Günay ^a   Hergenç, Gülay ^b   Onat, Allan ^c   Humphries, Steve E ^d   Erginel Ünaltuna, Nihan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^c Turkish Society of Cardiology   (Turkey)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CETP TaqlB; Dyslipidemia; HDL cholesterol; Logistic regression analysis; Metabolic syndrome; Turkish adults

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAQ POLYMERASE; CETP PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGE; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DNA ISOLATION; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC); WAIST HIP RATIO; BLOOD; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

BLOOD GLUCOSE; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TAQ POLYMERASE; TURKEY;

EID: 56049112591     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tall A. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255-74.
2. Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J, et al., Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994; 94: 1872-82.
3. Agellon LB, Quinet EM, Gillette TG, Drayna DT, Brown ML, Tall AR. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 1990; 29: 1372-6.
4. Callen DF, Hildebrand CE, Reeders S. Report of the second international workshop on human chromosome 16 mapping. Cytogenet Cell Genet 1992; 60: 158-67.
5. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham Study. Arterioscler Thromb Vasc Biol 2000; 20: 1323-9.
6. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, et al. Increased high-density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med 1990; 323: 1234-8.
7. Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 1987; 15: 4698.
8. Kondo I, Berg K, Drayna DT, Lawn RM. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipo protein levels. Clin Genet 1989; 35: 49-56.
9. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994; 14: 336-44.
10. Hannuksela ML, Liinamaa MJ, Kesaniemi VA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 1994; 110: 35-44.
11. Tenkanen H, Koskinen P, Kontula K, Aalto-Setala K, Manttari M, Manninen V, et al. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 1991; 87: 574-8.
12. Mitchell RJ, Earl L, Williams J, Bisucci T, Gasiamis H. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol 1994; 66: 13-25.
13. Fumeron F, Betoulle D, Luc G, Behague I, Ricard B, Poirier O, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664-71.
14. Kauma H, Savolainen MJ, Heikkila R, Rantala AO, Lilja M, Reunanen A, et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 1996; 97: 156-62.
15. Onat, A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10.
16. Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486-97.
17. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.
18. Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006; 55: 445-52.
19. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191: 182-90.
20. Hodoglugil U, Williamson DW, Huang Y, Mahley RW. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet 2005; 68: 118-27.
21. Yilmaz H, Isbir T, Aǧaçhan B, Karaali Z. Effects of cholesterol ester transfer protein TaqIB gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem Funct 2005; 23: 23-8.
22. Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesaniemi YA, Tahvanainen E, et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. Eur J Clin Invest 1999; 29: 116-28.
23. Boekholdt SM, Sacks FM, Jukema, JW, Shepherd J, Freeman DJ, McMahon AD, et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment individual patient meta-analysis of 13,677 subjects. Circulation 2005; 111: 278-87.
24. Corbex M, Poirier O, Fumeron F, Betoulle D, Evans A, Ruidavets JB, et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 2000; 19: 64-80.
25. de Grooth GJ, Klerkx AHEM, Stroes ESG, Stalenhoef AFH, Kastelein JJP, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res 2004; 45: 1967-74.
26. Arai H, Yamamoto A, Matsuzawa Y, Yasushi S, Yamada N, Oikawa S, et al. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb 2005; 12: 240-50.
27. Sandhofer A, Kaser S, Ritsch A, Laimer M, Engl J, Paulweber B, et al. Cholesteryl ester transfer protein in metabolic syndrome. Obesity 2006; 14: 812-8.